Superficial venules dredging preparation for treating cerebral arteriosclerosis

Abstract

Disclosed is a superficial venules dredging preparation for treating cerebral arteriosclerosis which comprises the constituents (by weight portion) of quercetin 2-6.35 g, kaempferide 1.5-4.6 g, isorhamnetin 0.35-1g, ginkgolides 1-3g, ginseng saponin 0.6-2g, and right amount of auxiliary materials.

Description

technical field

[0001] The invention relates to a medicine for treating cerebral arteriosclerosis, namely Xueluotong preparation. Background technique

[0002] Cerebral arteriosclerosis is a disease that seriously threatens human health and life. It is one of the diseases that middle-aged and elderly people are susceptible to. Cerebral arteriosclerosis can cause a series of serious complications if it is not cured for a long time, and it will bring serious burdens to patients and their families. . The cause is that cholesterol and fat are deposited deep in the arterial intima, and collagen fibers proliferate, which thickens the arterial intima, narrows the lumen, occludes small blood vessels, reduces blood vessel elasticity, roughs the vessel wall and forms atherosclerotic plaque, thereby reducing blood supply to the brain. However, at present, there is no specific treatment method for cerebral arteriosclerosis, whether it is Western medicine or traditional Chinese medicin...

Examples

Embodiment 1

[0027] Disperse 2g of quercetin, 2g of kaempferol, 1g of isorhamnetin, 3g of ginkgolides, and 1.5g of total ginsenosides in the solvent, add appropriate amount of flavoring agent, bacteriostat, and stabilizer, and after sterilization Packed into bottles, it can be made into liquid oral preparations such as 1000 units of syrup, oral liquid, mixture, and alcohol preparation.

Embodiment 2

[0029] Add 6.35g of quercetin, 3g of kaempferol, 0.6g of isorhamnetin, 2g of ginkgolides, and 2g of total ginseng saponins, according to the tablet process, add the excipients used to make the tablet for organic blending, granulate, and dry , can be compressed into 1,000 units of various types of tablets, such as ordinary tablets, dispersible tablets, effervescent tablets or sustained-release tablets that disintegrate in the stomach or intestines.

Embodiment 3

[0031] Add 4g of quercetin, 4.6g of kaempferol, 0.35g of isorhamnetin, 1g of ginkgolides, and 0.6g of total ginseng saponins into the molten matrix, mix well until they are fully dispersed, and drop in with In the immiscible condensate, control a certain speed to make it solidify into a round spherical shape to make 1000 unit drop pills.

technical field

[0001] The invention relates to a medicine for treating cerebral arteriosclerosis, namely Xueluotong preparation. Background technique

[0002] Cerebral arteriosclerosis is a disease that seriously threatens human health and life. It is one of the diseases that middle-aged and elderly people are susceptible to. Cerebral arteriosclerosis can cause a series of serious complications if it is not cured for a long time, and it will bring serious burdens to patients and their families. . The cause is that cholesterol and fat are deposited deep in the arterial intima, and collagen fibers proliferate, which thickens the arterial intima, narrows the lumen, occludes small blood vessels, reduces blood vessel elasticity, roughs the vessel wall and forms atherosclerotic plaque, thereby reducing blood supply to the brain. However, at present, there is no specific treatment method for cerebral arteriosclerosis, whether it is Western medicine or traditional Chinese medicin...

Examples

Embodiment 1

[0027] Disperse 2g of quercetin, 2g of kaempferol, 1g of isorhamnetin, 3g of ginkgolides, and 1.5g of total ginsenosides in the solvent, add appropriate amount of flavoring agent, bacteriostat, and stabilizer, and after sterilization Packed into bottles, it can be made into liquid oral preparations such as 1000 units of syrup, oral liquid, mixture, and alcohol preparation.

Embodiment 2

[0029] Add 6.35g of quercetin, 3g of kaempferol, 0.6g of isorhamnetin, 2g of ginkgolides, and 2g of total ginseng saponins, according to the tablet process, add the excipients used to make the tablet for organic blending, granulate, and dry , can be compressed into 1,000 units of various types of tablets, such as ordinary tablets, dispersible tablets, effervescent tablets or sustained-release tablets that disintegrate in the stomach or intestines.

Embodiment 3

[0031] Add 4g of quercetin, 4.6g of kaempferol, 0.35g of isorhamnetin, 1g of ginkgolides, and 0.6g of total ginseng saponins into the molten matrix, mix well until they are fully dispersed, and drop in with In the immiscible condensate, control a certain speed to make it solidify into a round spherical shape to make 1000 unit drop pills.